VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA

被引：0
|
作者：
Subramaniam, Bavani [1 ]
Roy, Debasish [1 ]
Woldegerima, Ayda [1 ]
Przystal, Justyna [2 ]
Zhang, Jie [3 ]
Laternser, Sandra [2 ]
Kritzer, Bettina [2 ]
Yadavilli, Sridevi [1 ]
Mueller, Sabine [2 ,3 ]
Packer, Roger [1 ,4 ]
Nazarian, Javad [1 ,2 ]
机构：
[1] Childrens Natl Hosp, Ctr Genet Med Res, Washington, DC USA
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Dept Oncol, Zurich, Switzerland
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Childrens Natl Hosp, Gilbert Family Neurofibromatosis Inst, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-38
引用
收藏
页数：1
相关论文
共 50 条
  • [21] POST-PROGRESSION TREATMENT AFTER VAL-083 WITH RADIATION IN NEWLY DIAGNOSED GBM MGMT UNMETHYLATED PATIENTS
    Guo, Cheng-chen
    Yang, Qun-ying
    Xi, Shao-yan
    Liao, Yi-xiang
    Li, De-pei
    Jiang, Xiao-bing
    Chen, Yin-sheng
    Ke, Chao
    Sai, Ke
    Schwartz, Richard
    Langlands, John
    Brown, Dennis
    Chen, Zhongping
    NEURO-ONCOLOGY, 2023, 25
  • [22] Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history
    Golebiewska, Anna
    Oudin, Anais
    Baus, Virginie
    Hau, Ann-Christin
    Klein, Eliane
    Steino, Anne
    Bacha, Jeffrey A.
    Niclou, Simone P.
    Brown, Dennis M.
    CANCER RESEARCH, 2020, 80 (16)
  • [23] LIPID REPLACEMENT THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
    Paret, Claudia
    Ersali, Sara
    Sandhoff, Roger
    ElMalki, Khalifa
    Roth, Lea
    Wehling, Pia
    Fliss, Barbara
    Lepadatu, Adina
    Frauenknecht, Katrin
    Faber, Jorg
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S320 - S321
  • [24] Enhanced in vitro activity of dianhydrogalactitol (VAL-083) in combination with platinum drugs: Impact of p53 and platinum-resistance
    Steino, Anne
    He, Guanghan
    Martinez-Rivera, Michelle
    Bacha, Jeffrey A.
    Brown, Dennis M.
    Siddik, Zahid H.
    CANCER RESEARCH, 2016, 76
  • [25] A road map for the treatment of pediatric diffuse midline glioma
    Koschmann, Carl
    Al-Holou, Wajd N.
    Alonso, Marta M.
    Anastas, Jamie
    Bandopadhayay, Pratiti
    Barron, Tara
    Becher, Oren
    Cartaxo, Rodrigo
    Castro, Maria G.
    Chung, Chan
    Clausen, Madison
    Dang, Derek
    Doherty, Robert
    Duchatel, Ryan
    Dun, Matthew
    Filbin, Mariella
    Franson, Andrea
    Galban, Stefanie
    Moure, Marc Garcia
    Garton, Hugh
    Gowda, Pruthvi
    Marques, Joana Graca
    Hawkins, Cynthia
    Heath, Allison
    Hulleman, Esther
    Ji, Sunjong
    Jones, Chris
    Kilburn, Lindsay
    Kline, Cassie
    Koldobskiy, Michael A.
    Lim, Daniel
    Lowenstein, Pedro R.
    Lu, Q. Richard
    Lum, Joanna
    Mack, Stephen
    Magge, Suresh
    Marini, Bernard
    Messinger, Dana
    Martin, Donna
    Marupudi, Neena
    Mody, Rajen
    Morgan, Meredith
    Mota, Mateus
    Muraszko, Karin
    Mueller, Sabine
    Natarajan, Siva Kumar
    Nazarian, Javad
    Niculcea, Michael
    Nuechterlein, Nicholas
    Okada, Hideho
    CANCER CELL, 2024, 42 (01) : 1 - 5
  • [26] Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors.
    Bacha, Jeffrey A.
    He, Guangan
    Xie, Xiaolei
    Steino, Anne
    Brown, Dennis M.
    Siddik, Zahid H.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 38 - 38
  • [27] The unique mechanism of action of VAL-083 may provide a new treatment option for some chemo-resistant cancers
    Steino, Anne
    Bacha, Jeffrey A.
    Garner, William J.
    Kanekal, Sarath
    Siddik, Zahid H.
    Brown, Dennis M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [28] Dianhydrogalactitol (VAL-083) for the treatment of glioblastoma multiforme (GBM): Impact of glucose transporters for crossing the blood brain barrier (BBB)
    Langlands, John M.
    Kanekal, Sarath
    Steino, Anne
    Mendez, Armando
    Karman, Zoltan
    Toth, Beata Martonne
    Heredi-Szabo, Krisztina
    Brown, Dennis
    CANCER RESEARCH, 2022, 82 (12)
  • [29] PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer
    Jhuraney, Ankita
    Woods, Nicholas T.
    Wright, Gabriela
    Rix, Lily
    Kinose, Fumi
    Kroeger, Jodi L.
    Remily-Wood, Elizabeth
    Cress, W. Douglas
    Koomen, John M.
    Brantley, Stephen G.
    Gray, Jhanelle E.
    Haura, Eric B.
    Rix, Uwe
    Monteiro, Alvaro N.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) : 1669 - 1681
  • [30] DNA-damaging agent dianhydrogalactitol (VAL-083) targets HR repair pathway and suggests combination therapy with topoisomerase and PARP inhibitors
    Zhai, Beibei
    He, Guangan
    Steino, Anne
    Bacha, Jeffrey A.
    Brown, Dennis M.
    Siddik, Zahid
    Daugaard, Mads
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345